News | October 11, 2023
Evonik introduces the world’s first carbon-fiber reinforced PEEK filament for 3D printed medical implants
Alignment of carbon-fiber can be controlled during the 3D printing process
Alignment of carbon-fiber can be controlled during the 3D printing process
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)
Subscribe To Our Newsletter & Stay Updated
